Maryland Prescription Drug Monitoring Program: Beginning July 1, 2018 PDMP use by Controlled Dangerous Substances (CDS) prescribers is mandatory
The Maryland Prescription Drug Monitoring Program (PDMP) is run by Chesapeake Regional Information System for our Patients (CRISP). The PDMP launched in late 2014, allowing physicians to access information online to assist them in identifying patients at risk for substance use disorders. The service can also help prevent dangerous drug interactions. The Maryland PDMP also includes out-of-state data.
Access to PDMP data is provided through the CRISP web-based query portal. All CDS prescribers were required to register with PDMP no later than July 1, 2017. To register, go to the CRISP website. A step-by-step guide to prescriber registration is available. Please note that an uploaded photo ID is needed to register, as well as the organization name that you work for. If you are self-employed, you will need to create an organization on the registration form. More information is on the Program’s webpage, or call 410-402-8686.
Beginning July 1, 2018 PDMP use by CDS prescribers is mandatory. Prescribers must, with some exceptions, query and review their patient’s PDMP data prior to initially prescribing an opioid or benzodiazepine AND at least every 90 days thereafter if the course of treatment continues to include prescribing an opioid or benzodiazepine. Prescribers must also document the PDMP data query and review in the patient’s medical record. More information is available in MedChi’s fact sheet and on the BHA PDMP website. In addition, a training video is available.